| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |